La empagliflozina disminuye la mortalidad cardiovascular y el riesgo de hospitalización en pacientes con insuficiencia cardíaca / Empagliflozin decreases cardiovascular mortality and the risk of hospitalization in heart failure patients
Evid. actual. práct. ambul
; 24(4): e002159, 2021. tab
Article
in Es
| LILACS, UNISALUD, BINACIS
| ID: biblio-1362082
Responsible library:
AR2.1
Full text:
1
Index:
LILACS
Main subject:
Benzhydryl Compounds
/
Cardiovascular Diseases
/
Sodium-Glucose Transporter 2 Inhibitors
/
Glucosides
/
Heart Failure
Type of study:
Clinical_trials
/
Etiology_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
Language:
Es
Journal:
Evid. actual. práct. ambul
Journal subject:
MEDICINA
/
PRESTACAO DE CUIDADOS DE SAUDE
Year:
2021
Type:
Article